This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Trouble With Non-tech Cofounders. I want to reflect on my experience as a non-technical founder and reassess my original decision – almost two years ago – to stick to what I’m good at, and not waste time learning to code. guest author. Thursday, February 23rd, 2012. Not convinced?
He was completing his undergraduate studies with a major in Management Information Systems at the University of Texas and was aspiring to a management consulting position. Brett started his career in technology development at a large global management and was a very strong performer. Back to Contents Written by Bob Campbell on Sept.
But we got serious in early 2016 when we developed deep conviction around the immense technical vision of Ethereum. Our investment thesis is simple: Blockchains will impact trillions of dollars of economic activity across many industries globally. We look for projects and protocols that can rethink major classes of global commerce.
This panel discussion will outline the initiative announced earlier this year at Davos with participating companies explaining their roles and how, together, public-private partnerships are essential to changing health outcomes globally. Cofounder and Director at Courier Therapeutics Kedar Karkare , PhD., FDA BLOCKCHAIN PILOT?—?WHAT
Austin Diversity Evangelists Mellie Price Director of Diversity Capital Factory Managing Director, Health CoLab Dell Medical School Mellie Price is a successful entrepreneur, angel investor, venture capitalist, and now university commercialization disruption at the Dell Medical School at the University of Texas. Carolyn was recognized by Inc.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content